Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08)
Journal of Pain and Symptom Management - Netherlands
doi 10.1016/j.jpainsymman.2019.06.020
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2019
Authors
Publisher
Elsevier BV